When and How Will COVID-19 End?
If you’re staying shut in your home, anxious about when you will finally be able to take a stroll outside or whether you or someone close to you will be infected by the novel coronavirus, you are not the only one. In the U.S. alone, half of the adults report high levels of anxiety due to the COVID-19, according to the American Psychiatric Association. The ongoing pandemic is exerting the whole world both physically and mentally. One thing is sure to be asked by everyone: when will all this be over? Some think that things will never get back to normal. Acclaimed sci-fi writer Ted Chiang says that “we don’t want everything to go back to business as usual, because business as usual is what led us to this crisis”. In this article, we explore scenarios about how COVID-19 will give us some rest and when it could happen. Getting a definite answer for these might be impossible. It will largely depend on actions from every level: scientists, governments and the general public, and how well we adhere to these. These vary from country to country, but with the help of technology, we can find answers for this public health crisis. Monitoring data from home In order to have an approximation of when one can see the light at the end of the coronavirus tunnel, people have been keeping track of the number of cases, which only keeps increasing. Online interactive dashboards like those from Johns Hopkins University and Microsoft are effective ways to kee...
Authors: Shi YQ, Qi WF, Kong CY Abstract Rheumatoid arthritis (RA), which normally manifests as a multi‑joint inflammatory reaction, is a common immunological disease in clinical practice. However, the pathogenesis of RA has not yet been fully elucidated. Rituximab (RTX) is an effective drug in the treatment of RA, however its therapeutic efficacy and mechanism of action require further investigation. Thus, the present study aimed to screen the candidate key regulatory genes and explain the potential mechanisms of RA. Gene chips of RA and normal joint tissues were analyzed and, gene chips of RTX before and after ...
In conclusion, TCGA classification based on a Chinese population is the same as TCGA typing based on a European population in terms of proportion and clinical characteristics, but there are differences in gene amplification and gene mutation. ACRG molecular classification could be performed by IHC analysis and may be a valuable independent prognostic marker for patients with GC. PMID: 32468041 [PubMed - as supplied by publisher]
This article proposes strategies to ensure the ongoing effectiveness, efficiency and engagement of lectures transitioning from face-to-face to online delivery. Cognitive learning theory, strategies to promote learner engagement and minimise distraction, and examples of software affordances to support active learning during the lecture are proposed. This enables lecturers to navigate the challenges of lecturing in an online environment and plan fruitful online lectures during this disruptive time. These suggestions will therefore enable HPE to better meet the existing and future needs of regional, rural and remote learners ...
Conclusions: 60% of patients with MDD and/or AAD had at least one additional NCCD, which significantly increased the economic and humanistic burden. These findings are important for payers and clinicians in making treatment decisions. These results underscore the need for development of multi-pronged interventions which aim to improve quality of life and reduce activity limitations among patients with mental health disorders and NCCDs. PMID: 32468879 [PubMed - as supplied by publisher]
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Publication date: Available online 29 May 2020Source: The Lancet Respiratory MedicineAuthor(s): James H Hull, Julie K Lloyd, Brendan G Cooper
Publication date: Available online 29 May 2020Source: The Lancet Respiratory MedicineAuthor(s): Talha Khan Burki
Publication date: Available online 29 May 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Alessandro Mantovani, Christopher D. Byrne, Ming-Hua Zheng, Giovanni Targher
Publication date: Available online 29 May 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Elisabetta Torlone, Camilla Festa, Gloria Formoso, Marina Scavini, Maria Angela Sculli, Elena Succurro, Laura Sciacca, Paolo Di Bartolo, Francesco Purrello, Annunziata Lapolla
New York City, the epicenter of the coronavirus pandemic in the U.S., is on track to slowly reopen. However, other states throughout the country are still experiencing increases in coronavirus cases. Tom Hanson reports.
More News: Agoraphobia | Allergy | Allergy & Immunology | Anxiety | China Health | Coronavirus | COVID-19 | Germany Health | Infectious Diseases | Information Technology | International Medicine & Public Health | Israel Health | John Hopkins University | Learning | Medical Ethics | Men | Middle East Health | National Institutes of Health (NIH) | Outbreaks | Pandemics | Physics | Psychiatry | Science | Singapore Health | Social Anxiety Disorder | South Korea Health | Sweden Health | Universities & Medical Training | Vaccines